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Abstract
Background: The GOLD.db (Genomics of Lipid-Associated Disorders Database) was developed
to address the need for integrating disparate information on the function and properties of genes
and their products that are particularly relevant to the biology, diagnosis management, treatment,
and prevention of lipid-associated disorders.
Description:  The GOLD.db http://gold.tugraz.at provides a reference for pathways and
information about the relevant genes and proteins in an efficiently organized way. The main focus
was to provide biological pathways with image maps and visual pathway information for lipid
metabolism and obesity-related research. This database provides also the possibility to map gene
expression data individually to each pathway. Gene expression at different experimental conditions
can be viewed sequentially in context of the pathway. Related large scale gene expression data sets
were provided and can be searched for specific genes to integrate information regarding their
expression levels in different studies and conditions. Analytic and data mining tools, reagents,
protocols, references, and links to relevant genomic resources were included in the database.
Finally, the usability of the database was demonstrated using an example about the regulation of
Pten mRNA during adipocyte differentiation in the context of relevant pathways.
Conclusions: The GOLD.db will be a valuable tool that allow researchers to efficiently analyze
patterns of gene expression and to display them in a variety of useful and informative ways, allowing
outside researchers to perform queries pertaining to gene expression results in the context of
biological processes and pathways.
Background
The excessive consumption of high calorie, high fat diets
and the adoption of a sedentary life style have made obes-
ity and atherosclerosis major health problems in Western
societies. In the USA, over 50% of the population are over-
weight (BMI > 25) and close to 25% are considered obese
(BMI > 30) [1,2]. As a consequence, a large fraction of the
population is at risk to develop a broad range of common,
life-threatening diseases including non-insulin dependent
diabetes, various hyperlipidemias, high blood pressure
and atherosclerosis. Vascular disease including coronary
heart disease and stroke is currently the major cause of
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death in the United States and in other industrialized
nations.
At the root of obesity and atherosclerosis is an excessive
deposition of neutral lipids. Adipose tissue accumulates
predominantly triglycerides, whereas macrophages along
the blood vessel wall mainly accumulate cholesterol and
cholesteryl esters. Accordingly, a detailed understanding
of the molecular mechanisms that govern the balance
between lipid deposition and mobilization is fundamen-
tally important for the prevention and improved treat-
ment of disease. In addition to the apparent
environmental components involved in the pathogenesis
of disorders related to lipid and energy metabolism, a
large number of studies have provided undisputed evi-
dence that susceptibility genes contribute around 50% of
the phenotype. These genes encode products involved in
the cellular uptake, synthesis, deposition and/or mobili-
zation of lipids. However, characterization of many if not
most of these genes and their products remains rudimen-
tary. Deficiencies in the current level of understanding
extend to key enzymes such as important triglyceride
hydrolases in adipose tissue [3] or cholesteryl ester hydro-
lases in macrophages, hormones, signal transduction
pathways, and the regulation of the transcription of rele-
vant genes.
While medical molecular biology traditionally associates
single genes and gene products with diseases, a growing
body of evidence suggests that several common disease
phenotypes arise from the delicate interaction of many
genes as well as gene-environment interactions. To eluci-
date the development of obesity and atherosclerosis, it
will be necessary to analyze patterns of gene expression
and relate them to various metabolic states. To discover
novel genes, processes and pathways that regulate lipid
deposition and mobilization, a departure from hypothe-
sis-driven research and turn to a discovery-driven
approach is necessary. The application of high-through-
put technologies and genome-based analysis will provide
the tools for the analysis of gene-gene and gene-environ-
ment interactions in a systematic and comprehensive
manner.
To facilitate genomic research we have initiated the devel-
opment of a system for storing, integrating, and analyzing
relevant data needed to decipher the molecular anatomy
of lipid associated disorders. In order to provide a refer-
ence for pathways and information of the relevant genes
and proteins in an efficiently organized way, we have cre-
ated the Genomics Of Lipid-Associated Disorders data-
base (GOLD.db). The GOLD.db integrates disparate
information on the function and properties of genes and
their protein products that are particularly relevant to the
biology, diagnosis management, treatment, and preven-
tion of lipid-associated disorders.
Construction and content
The main goal of the GOLD.db was to provide biological
pathways with image maps and visual pathway informa-
tion. For each element in the pathway, specific informa-
tion exists including structured information about a gene,
protein, function, literature, and links. The GOLD.db pro-
vides also the possibility to map gene expression data
individually to each pathway. Additionally, analytic and
data mining tools, reagents, protocols, references, and
links to relevant genomic resources were included in the
database.
The GOLD.db was implemented in Java technology [4].
Hence, the pathway editor, as well the web application are
platform independent. The web application of GOLD.db
is build in Java Servlets and JavaServer Pages technology
based on the Model-View-Controller Architecture [5]. For
the implementation, the freely available struts framework
[6] was used. This code can be easily deployed in any Serv-
let Container. We used the Servlet Container Tomcat (also
freely available at [7]) which is accessible from all web
browsers. Oracle 9i was used as database management
system. The interface between the Java and the Database
management system was established using Java database
connectivity (JDBC) 2.0. Therefore, migration to other
freely available DBMSs like mySQL can be easily done. For
additional storage and communication between the path-
way-editor components, the markup language XML con-
taining structured, human readable information, was
used. The provided pathways can be downloaded as Scal-
able Vector Graphics (SVG) [8], a standard for describing
two-dimensional graphics in XML, and can be visualized
in this format on the client side with the web browser
using a plug-in for SVG.
For tracking the repository of the reagents like clone
resources and libraries which can be used for microarray
studies, we have developed a relational database. Infor-
mation about the vector, the sequence and length of the
clone insert, primers for the PCR amplification, tissue,
organism, accession number, library, container, storage
information, date and person and access to other clone
bases (e.g. IMAGE Consortium) can be stored. Users of
the GOLD.db can list these clones and get all the informa-
tion about each available clone. With restricted access,
clone information or even clone lists can be uploaded and
selection lists can be created and deleted. The input mask
is designed in such way that the user can choose one of the
elements of the created selection lists.
In order to deal with the huge amount of data associated
with large scale studies and to perform sequence basedBMC Genomics 2004, 5:93 http://www.biomedcentral.com/1471-2164/5/93
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and microarray analysis, several bioinformatic tools were
integrated or can be downloaded. Sequence similarity
search against databases can be performed with BLAST
(Basic Local Alignment Search Tool) [9], FASTA [10] or
HMM (Hiden Markov Models) [11] on a 50 CPU Myrinet
Cluster. The sequence retrieval system SRS (LION Bio-
science AG, Heidelberg, Germany) was included to enable
rapid, easy and user friendly access to the large volumes of
diverse and heterogeneous data [12]. The latest version of
the PathwayEditor for the construction of biological path-
way diagrams can be downloaded. For microarray analy-
sis the platform independent JAVA tools ArrayNorm [13]
for normalization of microarray data and Genesis [14] for
clustering and analysis of large scale gene expression data-
sets were made available.
Utility and discussion
Pathways
In order to construct the biological pathways of interest,
we have developed a pathway editor [15] and an extended
version to map gene expression data (pathway mapper).
This drawing tool provides the possibility to draw ele-
ments – typically representing a gene as part of the path-
way – and the connection between those elements. The
benefit of this tool is that information can be appended to
each element via an input mask. This information can be
accessed by clicking on the corresponding element in the
image map within the pathway mapper or when saved
and uploaded via the web interface to the GOLD.db. To
design this pathway service as flexible as possible, features
are provided for the remove, up- and download of rele-
vant pathways (image maps) including the underlying
additional information of the elements. However, this
service is on a restricted basis to prohibit unauthorized
access. Since some pathways tend to become very detailed
an option to search for genes or gene accession number,
respectively, within the pathways was built in. The path-
way editor is executable as a standalone application and is
available from [16]. Currently annotated pathways are the
insulin signaling pathway, the IGF-1 pathway and the adi-
pogenesis regulatory network. Other pathways of lipid
metabolism will follow in the near future. Available
KEGG pathways can also be adapted with the pathway
editor based on the provided XML files [17] and uploaded
in the same way. All relevant KEGG pathways for different
organisms are provided. Moreover, pathways from Bio-
Carta were made available within the GOLD.db and
HTML files [18] were parsed to provide additional meta-
information of the pathway elements.
For each element in the pathways a specific information
field exists. The field includes structured information
about a gene, protein, function, literature, and links to
well-curated and annotated databases. Besides the gene
name and the symbol name – for human the HUGO sym-
bols and gene names and for mouse the MGI nomencla-
ture were used – RefSeq numbers for the transcript and the
protein as well as a link to SwissProt/UniProt and
LocusLink is available. For the elements of the KEGG
pathways a link to the provided enzyme or product infor-
mation was given. The description, localization and clas-
sification of the factors are entered by the annotator in
plain text and are accessed in the same format. The refer-
ences used to generate the content of the database entries
can be appended, including a link to the PubMed entry.
There is also the possibility to create a list of reference
entries for the pathway. If a clone for a specific gene is
available in the clone resources, the clone name will be
displayed automatically and a link with optional informa-
tion about this clone is provided.
Mapping of gene expression data sets to pathways
Through the integration of several types of biological
information deeper insights into the molecular mecha-
nisms and biological processes can be gained than just by
the analysis of one type of experimental results. In the
GOLD.db it is possible to map gene expression data (for
instance results of microarray studies) to the correspond-
ing elements of the available pathways similar to previous
efforts [19]. Either an individual or a provided gene
expression data set can be used to visualize the gene
expression at different experimental conditions sequen-
tially or all at once in the context of a pathway. If an ele-
ment (gene) of the pathway is included in the data set, the
related symbol in the image map is color coded according
to the relative gene expression or the log ratio in two color
microarray experiments, respectively.
As key for the mapped relation the RefSeq number [20] is
used. Hence, only those elements in the data set file are
mapped, where the RefSeq number in the data set is spec-
ified. For the KEGG pathways each element classified by
the enzyme classification number (EC) is virtually subdi-
vided into different corresponding RefSeq entries, since
one EC is represented by one or more RefSeq entries.
Curated gene expression data sets
Analysis of gene expression patterns in animal and cell
models for lipid-associated disorders will help to under-
stand the fundamental gene relations and regulatory
mechanisms responsible for the development of obesity
related diseases. The huge amount of data associated with
the analysis of large scale gene expression analysis raises
the demand of tools for storing, processing and retrieving
complex information. Although a number of studies have
been published and despite the requirements of some
journals to deposit microarray data in public databases
like GEO http://www.ncbi.nlm.nih.gov/geo/ or ArrayEx-
press http://www.ebi.ac.uk/arrayexpress/, it is still very
difficult for researchers to obtain the original data. WebBMC Genomics 2004, 5:93 http://www.biomedcentral.com/1471-2164/5/93
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sites with Supplementary information are not maintained
and/or not further developed. Hence, a database with a
large collection of curated datasets will be enormously
valuable for the community. Approaches to upload and
retrieve gene expression data were pursued within the
GOLD.db. Large scale gene expression data sets can be
uploaded in form of tab delimited text files (Stanford file
format) [21] as used for cluster analysis programs together
with additional information about the experimental con-
ditions and the citation for already published data sets.
Within those data sets the search for specific genes is pos-
sible to provide integrated visualization of gene expres-
sion levels in different studies and experimental
conditions.
Example for using GOLD.db: regulation of Pten during 
adipocyte differentiation
Recently, it was shown that insulin sensitivity, energy
expenditure, and thermogenesis were enhanced in adi-
pose-specific Pten-deficient (AdipoPten-KO) mice. Body
and adipose tissues weight in these mice were significantly
lower than those of control mice in spite of a larger food
intake [22]. We addressed the question how is the expres-
sion of the Pten gene regulated during adipocyte differen-
tiation in different models and experimental setups and in
which pathways is PTEN involved. The workflow for the
analysis is described in Figure 1. Pten (phosphatase and
tensin homolog deleted on chromosome 10) is known as
tumor suppressor gene and is a protein and lipid phos-
Various result tables from using GOLD.db to address the question  how is PTEN regulated during adipocyte differentiation (top  left: result of search in SRS for phosphatase and tensin homolog; top right: pathways, in which PTEN is involved; bottom left: rel- ative  gene expression levels of PTEN in different datasets; bottom right: PTEN dependent cell cyle pathway with mapped gene  expression levels) Figure 1
Various result tables from using GOLD.db to address the question  how is PTEN regulated during adipocyte differentiation (top 
left: result of search in SRS for phosphatase and tensin homolog; top right: pathways, in which PTEN is involved; bottom left: rel-
ative  gene expression levels of PTEN in different datasets; bottom right: PTEN dependent cell cyle pathway with mapped gene 
expression levels)BMC Genomics 2004, 5:93 http://www.biomedcentral.com/1471-2164/5/93
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phatase with the major substrate phosphatiylinositol
3,4,5-triphosphate (PIP3), as indicated in the annotated
insulin signaling pathway within the GOLD.db. In fact,
Pten regulates negatively the insulin signaling pathway in
3T3-L1 adipocytes [23].
During adipocyte differentiation cyclin dependent kinase
inhibitors, like p21 leads to a hypophosphorylation of the
Retinoblastoma protein (Rb) which allows binding to the
E2F transcription factor, causing cells to permanently exit
the cell cycle – a required step in adipocyte differentiation
called mitotic clonal expansion – before entering the ter-
minal differentiation state. pRb interacts physically with
adipogenic CCAAT/enhancer-binding proteins and posi-
tively regulates transactivation by C/EBPβ and therefore
plays a pivotal role in adipocyte differentiation [24,25].
Hence, since a) PTEN is expressed during adipogenesis
(Figure 1), b) is involved in the regulation of Rb [22], a
major player in adipogenesis, and c) is an important com-
ponent in cell cycle arrest and apoptosis (Figure 1), it can
be postulated that PTEN plays an important role in fat cell
development.
Thus, using recently identified key player for food intake
and weight control and using the GOLD.db, it is possible
to address relevant questions and generate testable
hypotheses on the molecular mechanisms of fat cell
development.
Conclusions
The vast quantity of gene expression data generated in
genomic studies presents a number of challenges for their
effective analysis and interpretation. In order to fully
understand the changes in expression that will be
observed, we must correlate these data with phenotype,
genotype, metabolism and other information including
the tissue distribution and time course expression data
gleaned from previous studies. The goal of our work was
the development of a specialized database and tools that
allow researchers to efficiently analyze patterns of gene
expression and to display them in a variety of useful and
informative ways, allowing outside researchers to perform
queries pertaining to gene expression results in the context
of biological processes and pathways. The uniqueness of
the GOLDdb database we have developed is threefold: 1)
the inclusion of annotated pathways, 2) the availability of
curated datasets and 3) the possibility to map experimen-
tal data on biological pathways. The upcoming challenges
will be to include data from functional analysis and pro-
teomics data, which will give us new opportunities in
understanding mechanisms of different applications and
lipid-associated disorders in particular.
Availability and requirements
The GOLD.db database should be cited with the present
publication as a reference. Access to GOLD.db is possible
through the world wide web at http://gold.tugraz.at. The
pathway editor and the clone tracker are available free of
charge to academic, government, and other nonprofit
institutions.
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